Literature DB >> 24430453

Sequence conservation of the region targeted by the Abbott RealTime HCV viral load assay.

Gavin Cloherty1, Neil Parkin, James Rhoads, Claudia Esping, Corklin Steinhart, George Schneider, Lily Yuen, John Hackett.   

Abstract

The Abbott RealTime (RT) HCV assay targets the 5' untranslated region (UTR) of the HCV genome. Here, we analyzed the sequence variability of the assay target regions from 1,092 specimens. Thermodynamic modeling of the percentage of primers/probes bound at the assay annealing temperature was performed to assess the potential effect of sequence variability. An analysis of this large data set revealed that the primer and probe binding sites of the RealTime HCV viral load assay are highly conserved and that naturally occurring sequence polymorphisms are not expected to discernibly impact assay performance.

Mesh:

Substances:

Year:  2014        PMID: 24430453      PMCID: PMC3993474          DOI: 10.1128/JCM.02661-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Meeting the challenge of HIV diversity: strategies to mitigate the impact of HIV-1 genetic heterogeneity on performance of nucleic acid testing assays.

Authors:  John Hackett
Journal:  Clin Lab       Date:  2012       Impact factor: 1.138

2.  Minimal sequence variability of the region of HIV-1 integrase targeted by the Abbott RealTime HIV-1 viral load assay in clinical specimens with reduced susceptibility to raltegravir.

Authors:  Thomas P Young; Laura A Napolitano; Agnes C Paquet; Neil T Parkin; Signe Fransen; Roger Trinh; Mojgan Haddad; John Hackett; Gavin A Cloherty
Journal:  J Virol Methods       Date:  2013-07-25       Impact factor: 2.014

3.  Futility rules for telaprevir combination treatment for patients with hepatitis C virus infection.

Authors:  Nathalie Adda; Doug J Bartels; Linda Gritz; Tara L Kieffer; Frank Tomaka; Leif Bengtsson; Don Luo; Ira M Jacobson; Robert S Kauffman; Gaston Picchio
Journal:  Clin Gastroenterol Hepatol       Date:  2012-11-14       Impact factor: 11.382

Review 4.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

5.  Evaluation of the Abbott investigational use only RealTime hepatitis C virus (HCV) assay and comparison to the Roche TaqMan HCV analyte-specific reagent assay.

Authors:  Michael T Pyne; Eric Q Konnick; Amit Phansalkar; David R Hillyard
Journal:  J Clin Microbiol       Date:  2009-07-22       Impact factor: 5.948

Review 6.  Genetic diversity and evolution of hepatitis C virus in the Latin American region.

Authors:  Juan Cristina
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

7.  Impact of hepatitis C virus (HCV) genotypes on quantification of HCV RNA in serum by COBAS AmpliPrep/COBAS TaqMan HCV test, Abbott HCV realtime assay [corrected] and VERSANT HCV RNA assay.

Authors:  Edouard Tuaillon; Anne-Marie Mondain; Laure Ottomani; Laurent Roudière; Pascal Perney; Marie-Christine Picot; Fabienne Séguret; François Blanc; Dominique Larrey; Philippe Van de Perre; Jacques Ducos
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

8.  Overestimation and underestimation of hepatitis C virus RNA levels in a widely used real-time polymerase chain reaction-based method.

Authors:  Stéphane Chevaliez; Magali Bouvier-Alias; Rozenn Brillet; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2007-07       Impact factor: 17.425

9.  GenBank.

Authors:  Dennis A Benson; Ilene Karsch-Mizrachi; David J Lipman; James Ostell; David L Wheeler
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

Review 10.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

View more
  1 in total

1.  Immiscible phase filter extraction and equivalent amplification of genotypes 1-6 of hepatitis C RNA: The building blocks for point-of-care diagnosis.

Authors:  Mário F Neto; Matthew A Butzler; Jennifer L Reed; Xiang Rui; Mark J Fisher; David M Kelso; Sally M McFall
Journal:  J Virol Methods       Date:  2017-06-30       Impact factor: 2.014

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.